Lab-grown meat, also called cultivated meat, is generally considered safe to eat based on current evidence. The FDA has completed safety reviews for cultivated chicken products and issued “no further questions” letters, meaning the agency found no safety concerns after evaluating the production process, cell lines, and manufacturing controls. That said, cultivated meat is still a new technology, and some safety questions remain open as production scales up.
How It’s Regulated in the U.S.
Cultivated meat falls under a joint oversight system split between the FDA and the USDA. The FDA handles everything from the initial cell collection through growing and multiplying cells in bioreactors. This includes evaluating the cell lines, the nutrient mixtures used to feed those cells, and the manufacturing controls in place. Once the cells are ready for harvest, oversight transfers to the USDA’s Food Safety and Inspection Service, which inspects facilities, runs product testing, verifies food safety plans, and ensures proper labeling.
Products must meet the same safety requirements as all other food sold in the U.S. In November 2022, the FDA completed its first pre-market consultation with UPSIDE Foods, a cultivated chicken company, and stated it had “no further questions” about the firm’s safety conclusion. A second company, GOOD Meat, received the same determination shortly after. These consultations involved detailed evaluation of production processes, cell bank establishment, and every input used during manufacturing.
Lower Risk of Foodborne Pathogens
One of the clearest safety advantages of cultivated meat is the near-elimination of common foodborne bacteria. In conventional meat production, muscle tissue in a living animal is sterile, but it picks up bacteria like Salmonella, E. coli, Campylobacter, and Listeria during slaughter and processing. Contaminated hides, feces, and the physical steps of removing skin and organs are the primary sources of these pathogens.
Cultivated meat sidesteps this entirely. Cells grow inside closed-loop stainless steel bioreactors under controlled, nominally sterile conditions similar to pharmaceutical manufacturing. There’s no animal gut, no hide, no slaughterhouse floor. A 2024 review in Comprehensive Reviews in Food Science and Food Safety noted that contamination from enteric zoonotic bacteria is “eliminated de facto” in this production model. The process uses cells that have been rigorously screened to exclude microbial contamination before they ever enter a bioreactor.
That doesn’t mean contamination is impossible. The very first stage, collecting cells from a living animal, still involves exposure to the animal, human staff, and laboratory environments. Producers need to test for bacteria at this stage. But once qualified cell banks are established and sealed into the production system, the risk of pathogen exposure drops dramatically compared to conventional meat.
The Cell Line Question
To produce cultivated meat at scale, companies need cell lines that can divide many more times than normal cells would. In nature, cells eventually stop dividing, a process called senescence. Producers work around this by creating immortalized cell lines, cells modified to keep multiplying through techniques like activating enzymes that maintain chromosome length.
This raises a question that comes up often: could these cells become cancerous, and would eating them be harmful? The concern is real enough that both the FAO/WHO and independent researchers have flagged genetic instability as a potential hazard requiring monitoring. Unintended genetic changes can occur during the many rounds of cell division involved in large-scale production, and in theory, cells could drift toward tumor-like behavior.
However, eating a cell with genetic mutations is not the same as those mutations affecting your body. You digest the proteins and other components just as you would from any food. The concern is less about cancer risk to the consumer and more about whether genetic drift could cause cells to produce unexpected or harmful substances. To manage this, producers run genetic stability assays, chromosome analyses, and tumorigenicity testing on their cell lines. Regulators evaluate this data as part of the pre-market review.
What Goes Into the Growth Medium
Cells don’t grow on their own. They need a nutrient-rich liquid called culture medium, which contains amino acids, sugars, vitamins, minerals, and signaling proteins called growth factors. Early cultivated meat research relied on fetal bovine serum, a costly and animal-derived ingredient, but the industry has been moving toward serum-free formulations.
The safety of every input in the culture medium falls under FDA review. Producers must demonstrate that all components and inputs are safe for the final food product. The process uses minimal to no animal-derived ingredients beyond the initial cells themselves, which limits the pathways for biological contamination. Antibiotics, commonly used in conventional animal farming and sometimes in lab cell culture to prevent bacterial growth, are a point of scrutiny. Regulators evaluate whether any residues could end up in the finished product.
Nutritional Gaps to Watch
Safety isn’t only about what’s harmful. It also matters whether cultivated meat delivers the nutrition people expect from real meat. On this front, there are genuine unknowns. Many of the vitamins, minerals, and flavor compounds found in conventional meat don’t originate in muscle cells. They come from the animal’s diet, are processed by its liver or other organs, and then accumulate in muscle tissue over the animal’s lifetime.
Cultivated muscle cells won’t contain these compounds unless they’re deliberately added to the culture medium and taken up by the cells. Vitamin B12 is a notable example: meat is a major dietary source of B12, but cultured cells won’t produce it on their own. Important minerals like zinc and selenium are either absent from standard cell culture media or present in very low concentrations. Protein content and composition may also differ from conventional meat, though detailed comparisons are still limited. If cultivated meat is marketed as a direct substitute for conventional meat, matching its nutritional profile will be important to avoid creating dietary gaps for consumers who make the switch.
Allergens and New Proteins
If you have a meat allergy, cultivated meat made from the same animal species would likely trigger the same reaction, since the cells produce the same proteins. But the production process introduces a wrinkle: the culture medium, scaffolding materials, and any genetic modifications could introduce proteins not found in conventional meat. A 2025 review on allergenicity in cultivated meat emphasized that any newly expressed proteins need comprehensive evaluation for allergenic potential. Researchers have proposed that cultivated meat should be checked for both known meat allergens and the possibility of novel sensitization from production-specific proteins. Regulatory frameworks are still catching up to formalize these assessments.
Scaffolds and Structure
To create products with texture (think a chicken breast rather than a paste), cells need something to grow on. These structures, called scaffolds, are typically made from edible materials like cellulose, soy protein, or other plant-derived fibers. Researchers are also exploring protein-based scaffolds that promote better cell adhesion and growth. Because the scaffold ends up in the finished product, the materials used need to be safe for consumption. Producers generally use ingredients that already have established safety records in the food supply, though the specific combinations and forms used in cultivated meat production are evaluated during regulatory review.
Global Regulatory Landscape
The U.S. isn’t the only country evaluating cultivated meat safety. Singapore became the first country to approve a cultivated meat product in 2020, requiring applicants to submit full safety assessments with scientific evidence demonstrating that the product poses no risk to human health. A joint FAO/WHO expert consultation reviewed the safety landscape and concluded that most hazards identified in cultivated meat are common to conventional food products. The experts recommended that regulators focus attention on materials, inputs, and equipment specific to cell-based production rather than treating it as an entirely new category of risk.
This finding is notable because it suggests cultivated meat doesn’t introduce a fundamentally different set of dangers. The risks are largely familiar ones (contamination, allergens, nutritional adequacy) showing up in an unfamiliar production context. The regulatory challenge is adapting existing food safety tools to monitor a new manufacturing process, not confronting an unknown class of hazard.